Jack Tasse
Direttore Finanziario/CFO presso DELIVRA HEALTH BRANDS INC.
Patrimonio netto: 37 700 $ in data 31/05/2024
Profilo
Jack Tasse currently works at Standard Mercantile Acquisition Corp., as Chief Financial Officer from 2021 and Delivra Health Brands, Inc., as Chief Financial Officer & Secretary from 2020.
Mr. Tasse also formerly worked at Therapure Biopharma, Inc., as Finance Director from 2012 to 2016 and Molecular Science Corp., as Chief Financial Officer from 2018 to 2020.
Mr. Tasse received his graduate degree from Brock University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 12/12/2023 | 1 300 000 ( 0.42% ) | 37 700 $ | 31/05/2024 |
Posizioni attive di Jack Tasse
| Società | Posizione | Inizio |
|---|---|---|
| DELIVRA HEALTH BRANDS INC. | Direttore Finanziario/CFO | 01/12/2020 |
| TREZ CAPSNRMTG INV A | Direttore Finanziario/CFO | 01/01/2021 |
Precedenti posizioni note di Jack Tasse
| Società | Posizione | Fine |
|---|---|---|
Molecular Science Corp.
 Molecular Science Corp. Miscellaneous Commercial ServicesCommercial Services Molecular Science Corp. provides laboratory services. The firm offers GC-MS and LC-MS analysis, cannabis laboratory testing services, mobile testing services, and scientific resources. The company was founded by Scott R. Walters and Sameet Kanade on January 24, 2017 and is headquartered in Toronto, Canada. | Direttore Finanziario/CFO | 01/03/2020 |
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Direttore Finanziario/CFO | 01/01/2016 |
Formazione di Jack Tasse
| Brock University | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| DELIVRA HEALTH BRANDS INC. | Process Industries |
| TREZ CAPSNRMTG INV A | Finance |
| Aziende private | 2 |
|---|---|
Molecular Science Corp.
Molecular Science Corp. Miscellaneous Commercial ServicesCommercial Services Molecular Science Corp. provides laboratory services. The firm offers GC-MS and LC-MS analysis, cannabis laboratory testing services, mobile testing services, and scientific resources. The company was founded by Scott R. Walters and Sameet Kanade on January 24, 2017 and is headquartered in Toronto, Canada. | Commercial Services |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Jack Tasse
